I flagged up Hawkwing (HNG) as worth a punt last week at a 5p offer and at up to 5.5p. The shares are now 8.5p-9.5p as folks too mean and stupid to subscribe to this website pile in on the momentum.

Hello Share Takers. We all know there’s a huge change coming over the way we get from A to B. We can tell from the surge of adverts on TV that the age of petrol cars is coming to an end after more than a century. And it’s not just cars undergoing the change. Also being urgently electrified are lorries, buses and trains…

I note the comments on gold by Lucian Miers HERE and Nigel Somerville HERE. Are the bulls in retreat? Well I am not and I explain why. Like Lucian, I am attracted to non-gold metals, even if Colin Bird is involved, but I am still c25% weighted in gold and happy to be so.

Gold, copper and silver producer in Azerbaijan Anglo Asian Mining (AAZ) has made a “Q4 and Full Year 2020 Production and Operations” announcement, noting Q4 full-year production of 67,249 gold equivalent ounces – suggesting Q4 of 16,542 such ounces – and that it is looking to “take advantage of the current market to expand.”

Welcome to the Sunday ShareProphets Pub Quiz. Find your own beer, sit in the most comfortable seat, and, under no circumstances, can you Google the answer. Only I can do that. There are no prizes but post your scores in the comments for bouquets and brickbats.

I can understand why people aren’t rushing to invest in the travel sector currently as the situation looks very bleak with Covid worsening and further travel restrictions and lockdowns being added on a daily basis around the world.

Here are five long reads that have nothing to do with shares. Put the kettle on, find a comfy chair. You have the time, don’t you? 

It was all looking so rosy. The correction from $2063 which started last August seemed to have played out, a low had been put in at $1776 and recovery was well on the way as the yellow metal rose and rose again to over $1950. And then we hit a bump in the road and we’re back down to around $1830. Even ShareProphets’ favourite technical analyst was taken aback by the drop: I hate to say it, but it looks as though Jordan Roy-Byrne of TheDailyGold.com has finally got something wrong!

Yesterday, I was offline from ShareProphets for most of the afternoon due to a snowstorm here in Canada that knocked out my Internet. Tom wanted to see some pictures, which you can see below. The third one is right in front of the house – that’s some guy who has drilled a hole and is ice fishing. At the time of the photo, he had not caught anything. Now, on to the most read articles.

It is the madness of crowds and that is what we are seeing today

I start with yesterday’s Albanian lecture in honour of my late father. Then it is onto Colin Bird and Jubilee Metals (JLP), Rio Ferdinand and the Gym Group (GYM) and Toxic Dave Sefton and Iconic (ICON) in the wake of Nigel’s bombshell from earlier. One of the three is a bit of a hero and, to give you a clue neither Bird or toxic Dave ever played for West Ham.  But would you want any of the three on the board of a company in which you are invested. I discuss all three situations in detail.

“With one bound Dick was free.” Not quite. But Metals Exploration (MTL) looks to be well on its way to overcoming its many travails and the company chief, Darren Bowden (not Dick Barton) is very excited about the year ahead.

Making SkinBioTherapeutics (SBTX) one of our three tips of the year 2021, we noted we considered it likely to make 2021 a breakthrough year, including with a planned first quarter human study for AxisBiotix™ targeting psoriasis and then, subject to a positive readout, commencing commercialisation. Already we now have an “Enrolment for AxisBiotix-PsT study commences” announcement and the shares are already massively higher than our 15.5p tip price at 29p. But you’d be mad to sell.

Yesterday Tom Winnifrith commented on a cash shell, Hawkwing (HNG) and promptly the share price took-off causing Tom to comment on the irrationality of cash shell valuations in yesterday’s bearcast. That has triggered me to write about a share I’ve looked at on and off over the last week or so. Wildcat Petroleum (WCAT) – the most bonkers cash shell valuation on the London market.

Oh dear, oh dear: things seem to be going from bad to worse at David Sefton’s former (and apparently still currently) stamping ground Iconic Labs (ICON). Last night at 5.35pm, 15% shareholder OTT Holdings released a statement announcing it has requested an EGM with a view to changing three (out of four) of the board as the major shareholder considers share price performance, lack of financing, management and board performance and now a lawsuit for breaching a financing agreement. Oh…..and toxic Dave Sefton gets a mention in despatches as well. It’s beer and popcorn time!

From the FCA’s spreadsheet of short positions required to be disclosed to it, the following shows the shorted AIM shares with positions from 2019, 2020 and thus far in 2021 (by net short position %, those in bold not on the list at the start of 2021) – and if this position has increased (red), reduced (green) or remained unchanged (black) since last week…

Hello, Share Shapers. So the UK economy shrunk by 2.6% in November. As England was put into lockdown for the second time and Wales and Scotland were also restricted, I believe most of us expected a bigger drop than that. The effect on most shares should be an upward thrust if that’s the best the Covid response can do to our GDP. 

I start with Jubilee Metals (JLP) where I am way ahead but have had enough. The shares are cheap but I have had enough of Colin Bird spouting utter bollocks. After today, I now own more shares in this company than Bird but that is going to change. Soon, like me and Lance Armstrong with accepted Tour de France wins, we will be neck and neck. Then I look at Hawkwing (HNG), Babcock (BAB) and Conduity Capital (CCAP) run by scumbag Greg Collier.

We’ve produced an update on a positive trading statement from J Sainsbury (SBRY) but it is not the only one in its sector that, despite recent gains, looks to offer long-term income value…

A start of this week trading statement from UK developer of beauty, personal care and life sciences products InnovaDerma (IDP) noted some “encouraging growth” and that it “will be exploring options to strengthen the balance sheet to ensure it is in a strong position to benefit from the substantial growth opportunities anticipated once restrictions begin to ease”. Today a “Loan Agreement”…